SIB 1508Y

Known as: SIB-1508Y 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
(S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), is a subtype-selective neuronal nicotinic… (More)
Is this relevant?
2006
2006
  • Neurology
  • 2006
This randomized, placebo-controlled, 5-week Phase II trial evaluated the safety and tolerability of SIB-1508Y, a selective… (More)
Is this relevant?
2000
2000
Rationale: Epidemiological studies of smokers suggest that there is a link between nicotine and depression. Nonetheless, few… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2000
2000
Neuronal nicotinic acetylcholine receptors (nAChRs) are a class of ion channels with significant potential as molecular targets… (More)
Is this relevant?
1999
1999
Monkeys that receive chronic low-dose 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine (MPTP) administration have difficulty… (More)
Is this relevant?
1999
1999
Monkeys that receive chronic low-dose 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP) administration have difficulty… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1998
1998
The potential antiparkinsonian effects of the centrally acting, subtype-selective neuronal nicotinic acetylcholine receptor… (More)
Is this relevant?
Review
1998
Review
1998
This study assessed the relative potencies of levodopa/benserazide and the nicotinic acetylcholine receptor agonist SIB-1508Y on… (More)
Is this relevant?
Review
1998
Review
1998
Neuronal nicotinic acetylcholine receptors (NAChRs) are pentameric ligand-gated ion channel receptors which exist as different… (More)
Is this relevant?